Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oramed Pharmaceuticals (ORMP) Current Taxes (2022 - 2026)

Oramed Pharmaceuticals filings provide 4 years of Current Taxes readings, the most recent being $3.3 million for Q4 2025.

  • Quarterly Current Taxes rose 2.56% to $3.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.3 million through Dec 2025, up 2.56% year-over-year, with the annual reading at $3.3 million for FY2025, 2.56% up from the prior year.
  • Current Taxes hit $3.3 million in Q4 2025 for Oramed Pharmaceuticals, down from $3.5 million in the prior quarter.
  • Across five years, Current Taxes topped out at $3.8 million in Q1 2025 and bottomed at $11000.0 in Q4 2022.
  • Average Current Taxes over 4 years is $1.4 million, with a median of $177500.0 recorded in 2022.
  • The largest annual shift saw Current Taxes changed 0.0% in 2023 before it soared 34336.36% in 2025.
  • Oramed Pharmaceuticals' Current Taxes stood at $11000.0 in 2022, then changed by 0.0% to $11000.0 in 2023, then skyrocketed by 29027.27% to $3.2 million in 2024, then rose by 2.56% to $3.3 million in 2025.
  • Per Business Quant, the three most recent readings for ORMP's Current Taxes are $3.3 million (Q4 2025), $3.5 million (Q3 2025), and $344000.0 (Q2 2025).